The pharmaceutical industry is ready to fall off a cliff — a “patent cliff.” Over the next few years, some of the world’s most popular and lucrative medicines will go off patent, and generic competition will siphon an estimate…
Samsung Electronics is known for its smartphones, TVs and memory chips. Now it wants to tackle biopharmaceuticals, on Friday announcing a new joint venture to produce drugs to treat cancer and arthritis. Here’s why the move cou…
“Do not not divide, crush, chew, or dissolve the tablet,” reads the label on packages of Johnson & Johnson’s Sudafed allergy and cold medicine. The company is recalling 667,632 packages for the typographical error.
…
Vertex Pharmaceutical shares soared 15% Wednesday as Wall Street cheered the results of a late-stage study of its new cystic fibrosis drug, an experimental treatment that targets the underlying cause of the disease rather than …
New Jersey Gov. Chris Christie has made autism services a priority in his proposed budget for the 2012 fiscal year. But some services may still suffer cuts: nonprofit Autism NJ says it’s set to lose a state contract — and Medi…